HRTX
USDHeron Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$1.170
High
$1.190
Low
$1.070
Volume
1.54M
Company Fundamentals
Market Cap
202.6M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.92M
Exchange
NCM
Currency
USD
52-Week Range
Related News
Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress
Generated Q3 2025 Net Revenue of $38.2 million and year-to-date revenue of $114.3 million; reaffirmed 2025 Net Revenue Guidance of $153 million - $163 million and adjusted EBITDA of $9.0 - $13.0 millionZYNRELEF® Net
Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors
CARY, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the appointment of Thomas Cusack to its Board
Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
CARY, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a conference call
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.